Previous Western meta-analyses [28, 29] and individual studies [12, 17] have observed a correlation between earlier menarche and higher BC risk in BRCA1 mutation carriers, whereas we observed these associations in BRCA2 mutations or non-carriers with FH. This evidence concerns the gene BRCA2 and breast cancer.